Cargando…

Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis

BACKGROUD: Mycophenolate mofetil (MMF) has been recommended for the treatment of lupus nephritis (LN). Although inter-racial differences exist regarding the appropriate dose and efficacy of MMF in patients with LN, no definitive meta-analysis has yet been conducted in Chinese patients. This analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Haitao, Zhou, Minlin, Han, Xiaoyan, Yang, Yang, Yu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	6900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437744/ https://www.ncbi.nlm.nih.gov/pubmed/32871981 http://dx.doi.org/10.1097/MD.0000000000021121

Ejemplares similares

Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis
por: Jiang, Yue-Peng, et al.
Publicado: (2020)

Monocyte chemoattractant protein-1 (MCP-1)-2518 A/G polymorphism and lupus nephritis risk: A PRISMA-compliant meta-analysis
por: Sang, Guo-Yao, et al.
Publicado: (2017)

Relationship of miRNA-146a to systemic lupus erythematosus: A PRISMA-compliant meta-analysis
por: Fan, Yihua, et al.
Publicado: (2020)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Gastrointestinal Henoch–Schönlein purpura successfully treated with Mycophenolate Mofetil: Description of 2 case reports
por: Gicchino, Maria Francesca, et al.
Publicado: (2021)

Oriental medicine as collaborating treatments with conventional treatments for knee osteoarthritis: A PRISMA-compliant systematic review and meta-analysis
por: Park, Yeon-Cheol, et al.
Publicado: (2023)

Systemic sclerosis and risk of cardiovascular disease: A PRISMA-compliant systemic review and meta-analysis of cohort studies
por: Cen, Xintao, et al.
Publicado: (2020)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

The value of repeat biopsy in lupus nephritis flares
por: Narváez, Javier, et al.
Publicado: (2017)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
por: Kise, Tomoo, et al.
Publicado: (2015)

Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
por: Rezaieyazdi, Zahra, et al.
Publicado: (2014)

Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015)

Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report
por: Li, Ling, et al.
Publicado: (2021)

Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
por: Nawata, Takashi, et al.
Publicado: (2017)

Histopathological Diagnostic Value of the IgG4(+)/IgG(+) Ratio of Plasmacytic Infiltration for IgG4-Related Diseases: A PRISMA-Compliant Systematic Review and Meta-Analysis
por: Deng, Chuiwen, et al.
Publicado: (2015)

Silica-associated systemic lupus erythematosus with lupus nephritis and lupus pneumonitis: A case report and a systematic review of the literature
por: Fukushima, Kazuhiko, et al.
Publicado: (2022)

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
por: Moore, R Andrew, et al.
Publicado: (2006)

The application of the Chinese version of the Body Image Disturbance Questionnaire in patients with systemic lupus erythematosus
por: Chen, Haoyang, et al.
Publicado: (2021)

The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease
por: Dalton, Kristen, et al.
Publicado: (2010)

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)
por: Galindo-Izquierdo, María, et al.
Publicado: (2016)

Predicting factors of adverse pregnancy outcomes in Thai patients with systemic lupus erythematosus: A STROBE-compliant study
por: Louthrenoo, Worawit, et al.
Publicado: (2021)

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
por: Mao, Youying, et al.
Publicado: (2018)

Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis
por: Almutairi, Abdulaziz, et al.
Publicado: (2018)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
por: Hackl, A., et al.
Publicado: (2023)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Chinese herbal compound prescription for systemic lupus erythematosus: A protocol for systematic review and meta-analysis
por: Luo, Yehao, et al.
Publicado: (2020)

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
por: Tamirou, Farah, et al.
Publicado: (2016)

Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case–control study
por: Dong, Xiwen, et al.
Publicado: (2018)

The correlational research among serum CXCL13 levels, circulating plasmablasts and memory B cells in patients with systemic lupus erythematosus: A STROBE-compliant article
por: Fang, Chenglong, et al.
Publicado: (2017)

Survival and prognosis analysis of systemic lupus erythematosus patients with pulmonary hypertension: A systematic review and meta-analysis
por: Yang, Jianguo, et al.
Publicado: (2023)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

Efficacy of High-Dose Mycophenolate Mofetil in Multitarget Therapy for Lupus Nephritis: Two Consecutive Case Reports
por: Furuto, Yoshitaka, et al.
Publicado: (2020)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

MTHFR polymorphisms (rs1801133) and systemic lupus erythematosus risk: A meta-analysis
por: Zhou, Huang-yan, et al.
Publicado: (2020)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios may not be useful markers to assess disease activity in rheumatoid arthritis: A STROBE-compliant article
por: Lijuan, Wang, et al.
Publicado: (2021)

Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension
por: Machireddy, Kirthi, et al.
Publicado: (2018)

Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis
por: Nee, Robert, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mo9pq1bkmngbf3khp2qrh9cu6j